Seroatlas · Human Serome Atlas

NUS1

Dehydrodolichyl diphosphate synthase complex subunit NUS1

Also known as: C6orf68, MGC7199, NgBR, NGBR_HUMAN, TANGO14

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q96E22
Gene
NUS1
Ensembl
ENSG00000153989
Chromosome
6
Canonical length
293 aa
Protein class
Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins
Subcellular location
Vesicles,Plasma membrane

OverviewNCBI Gene

This gene encodes a type I single transmembrane domain receptor, which is a subunit of cis-prenyltransferase, and serves as a specific receptor for the neural and cardiovascular regulator Nogo-B. The encoded protein is essential for dolichol synthesis and protein glycosylation. This gene is highly expressed in non-small cell lung carcinomas as well as estrogen receptor-alpha positive breast cancer cells where it promotes epithelial mesenchymal transition. This gene is associated with the poor prognosis of human hepatocellular carcinoma patients. Naturally occurring mutations in this gene cause a congenital disorder of glycosylation and are associated with epilepsy. A knockout of the orthologous gene in mice causes embryonic lethality before day 6.5. Pseudogenes of this gene have been defined on chromosomes 13 and X. [provided by RefSeq, May 2017]

Canonical amino-acid sequenceUniProt

293 residues, UniProt reviewed canonical sequence.

>Q96E22|NUS1
     1  MTGLYELVWR VLHALLCLHR TLTSWLRVRF GTWNWIWRRC CRAASAAVLA PLGFTLRKPP
    61  AVGRNRRHHR HPRGGSCLAA AHHRMRWRAD GRSLEKLPVH MGLVITEVEQ EPSFSDIASL
   121  VVWCMAVGIS YISVYDHQGI FKRNNSRLMD EILKQQQELL GLDCSKYSPE FANSNDKDDQ
   181  VLNCHLAVKV LSPEDGKADI VRAAQDFCQL VAQKQKRPTD LDVDTLASLL SSNGCPDPDL
   241  VLKFGPVDST LGFLPWHIRL TEIVSLPSHL NISYEDFFSA LRQYAACEQR LGK

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against NUS1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Other membrane
Secreted
No
Transmembrane segments
3
Mean surface accessibility (rSASA)
0.37
Highest tissue expression
57 nTPM

Expression across tissuesHPA

Tissue

  • cervix: 57 nTPM
  • thyroid gland: 33 nTPM
  • liver: 30 nTPM
  • salivary gland: 29 nTPM
  • parathyroid gland: 28 nTPM
  • epididymis: 27 nTPM

Single-cell type

  • mucous neck cells: 95 nCPM
  • monocyte progenitors: 93 nCPM
  • extravillous trophoblasts: 88 nCPM
  • pdcs: 83 nCPM
  • plasma cells: 81 nCPM
  • syncytiotrophoblasts: 79 nCPM

Immune cell

  • plasmacytoid DC: 3.8 nTPM
  • non-classical monocyte: 2.5 nTPM
  • basophil: 1.9 nTPM
  • MAIT T-cell: 1.9 nTPM
  • NK-cell: 1.9 nTPM
  • memory CD8 T-cell: 1.8 nTPM

Brain region

  • choroid plexus: 26 nTPM
  • hypothalamus: 21 nTPM
  • basal ganglia: 19 nTPM
  • cerebral cortex: 19 nTPM
  • midbrain: 19 nTPM
  • hippocampal formation: 18 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about NUS1.

Disease | AllUniProt

Conditions NUS1 is implicated in, by any mechanism.

Disease | GeneticClinVar

86 pathogenic / likely-pathogenic of 506 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.25
gnomAD pLI
0.98
gnomAD missense Z
0.88
DepMap mean gene effect
-1.4
DepMap dependency class
common

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of NUS1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads NUS1 as an antibody target. Whether an autoantibody or antibody against NUS1 could matter depends on whether native NUS1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

NUS1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label NUS1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/NUS1. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...